序号 |
标题 |
次数 |
作者 |
发布时间 |
76681 |
cas:1225964-49-7,4-Formyl-N-(2-(2-isopropylphenoxy)ethyl)benzamide |
70 |
wyh |
2024-12-18 |
76682 |
HS-PEG3-CH2CH2NH2 hydrochloride |
92 |
zyl |
2024-12-18 |
76683 |
米托蒽醌脂质体,Mitoxantrone,liposomes,Mit-lipo,提供荧光脂质体定制服务 |
242 |
axc |
2024-12-18 |
76684 |
MAL-tri-EG-OPFP,蛋白酶可裂解的连接子 |
97 |
WYQ |
2024-12-18 |
76685 |
MAL-tetra-EG-OPFP,蛋白酶可裂解的连接子 |
114 |
WYQ |
2024-12-18 |
76686 |
CAS:1263044-88-7,Mal-Ph-CONH-PEG4-NHS ester ,马来酰亚胺-PH-CONH-四聚乙二醇-琥珀酰亚胺酯 |
75 |
kx |
2024-12-18 |
76687 |
cas:2101206-50-0,2,5-Dioxopyrrolidin-1-Yl 1-(cyclooct-2-Ynyloxy)-2-Oxo-6,9,12,15-Tetraoxa-3-Azaoctadecan-18-Oate,ADC定制 |
83 |
wyh |
2024-12-18 |
76688 |
Fmoc-Phe-Lys(Trt)-PAB-PNP(CAS:1116086-09-9) |
82 |
WYQ |
2024-12-18 |
76689 |
cas:178106-34-8,2,5-dioxopyrrolidin-1-yl 3-hydroxypropanoate,ADC定制 |
110 |
wyh |
2024-12-18 |
76690 |
Py-ds-Prp-OPFP是另一种在ADC中常用的连接子 |
108 |
WYQ |
2024-12-18 |
76691 |
MAL-HA-OSu是一种在抗体药物偶联物(ADC)中常用的连接子(Linker) |
116 |
WYQ |
2024-12-18 |
76692 |
Thiol-PEG24-acid 巯基二十四聚乙二醇羧基 |
109 |
zyl |
2024-12-18 |
76693 |
CAS:485800-27-9,Boc-NH-ethyl-SS-propionic acid ,3-((2-((叔丁氧基羰基)氨基)乙基)二硫基)丙酸 |
93 |
kx |
2024-12-18 |
76694 |
cas:1225964-74-8,4-Formyl-N-(2-(2,4,5-trimethylphenoxy)ethyl)benzamide,ADC定制 |
122 |
wyh |
2024-12-18 |
76695 |
NOTA-PODS-ZEGFR:03115 NOTA缀合苯基噁二唑基甲基砜衍偶联EGFR靶向亲和体分子ZEGFR:03115 |
137 |
h |
2024-12-18 |
76696 |
Mal-NH-PEG8-CH2CH2COOPFP ester |
136 |
zyl |
2024-12-18 |
76697 |
SS-bis-amino-PEG4-NHS ester,ADC定制 |
80 |
kx |
2024-12-18 |
76698 |
3p-C-NOTA 双功能螯合剂 |
93 |
h |
2024-12-18 |
76699 |
cas:663599-05-1,DMAC-SPDB,ADC定制 |
121 |
wyh |
2024-12-18 |
76700 |
HS-PEG6-CH2CH2-Boc |
81 |
zyl |
2024-12-18 |
76701 |
NOTA-RGD-ATWLPPR 环状螯合剂NOTA偶联RGD-ATWLPPR异二聚体肽 |
77 |
h |
2024-12-18 |
76702 |
Fmoc-Gly-Gly-Phe-Gly-NH-CH2-O-CO-CH3 |
99 |
zyl |
2024-12-18 |
76703 |
cas:872679-70-4,Fmoc-NH-PEG2-CH2CH2COOH,ADC定制 |
123 |
wyh |
2024-12-18 |
76704 |
Hydroxy-PEG1-(CH2)2-Boc |
77 |
zyl |
2024-12-18 |
76705 |
NOTA-panitumumab F(ab)(2)NOTA-帕尼单抗F(ab)(2)片段 |
83 |
h |
2024-12-18 |
76706 |
CAS:756525-91-4,Boc-NH-PEG4-CH2CH2COOH ,15-(Boc-氨基)-4,7,10,13-四氧杂十五烷酸 |
114 |
kx |
2024-12-18 |
76707 |
NOTA-RGD-cys-6-Ahx-GE11 RGD-GE11异二聚体偶联6-氨基己酸(6-Ahx)和半胱氨酸缀合NOTA |
117 |
h |
2024-12-18 |
76708 |
Thalidomide-NH-(CH2)2-NH-Boc |
84 |
zyl |
2024-12-18 |
76709 |
cas:1137109-21-7,PEGylated,ADC定制 |
116 |
wyh |
2024-12-18 |
76710 |
Hydroxy-PEG3-CH2-Boc 可用于合成 PROTAC 分子 |
95 |
zyl |
2024-12-18 |
76711 |
Ala-Ala-Asn-PAB (CAS: 2149584-00-7) |
118 |
WYQ |
2024-12-18 |
76712 |
NOTA-amatuximab NOTA-MORAb-009 螯合剂NOTA偶联阿麦妥单抗 |
80 |
h |
2024-12-18 |
76713 |
cas:1870916-87-2,Mc-Val-Ala-PAB,ADC定制 |
88 |
wyh |
2024-12-18 |
76714 |
CAS:253863-34-2,Aloc-D-Ala-Phe-Lys(Aloc)-PAB-PNP, ADC试剂 |
107 |
kx |
2024-12-18 |
76715 |
NOTA-NEB Evans蓝的NOTA共轭截短形式NEB |
126 |
h |
2024-12-18 |
76716 |
Py-ds-dmBut-OPFP (CAS: 2101206-44-2) |
67 |
WYQ |
2024-12-18 |
76717 |
Hydroxy-PEG12-CH2-Boc |
85 |
zyl |
2024-12-18 |
76718 |
cas:106627-54-7,N-Hydroxysulfosuccinimide sodium,ADC定制 |
116 |
wyh |
2024-12-18 |
76719 |
Py-ds-dmBut-OSu (CAS: 890409-85-5) |
90 |
WYQ |
2024-12-18 |
76720 |
Mal-PEG4-bis-PEG4-propargyl,ADC定制 |
145 |
kx |
2024-12-18 |
76721 |
MC-GGFG-NH-CH2-O-CH2-cyclopropane-COOH |
78 |
zyl |
2024-12-18 |
76722 |
cas:1137109-22-8,2,5-Dioxopyrrolidin-1-yl,ADC定制 |
73 |
wyh |
2024-12-18 |
76723 |
alpha-Man-TEG-N3,246855-76-5,1-O-(2-(2-(2-叠氮乙氧基)乙氧基)乙氧基)-α-D-吡喃甘露糖苷 |
92 |
zyl |
2024-12-18 |
76724 |
CAS:882847-34-9,Fmoc-NH-PEG6-CH2CH2COOH ,Fmoc-21-氨基-4,7,10,13,16,19-六氧杂二十一烷酸 |
152 |
kx |
2024-12-18 |
76725 |
Fmoc-H2Lys(Boc)-OH, Fmoc-Dihomolysine(Boc)-OH, Fmoc-L-Dihomolysine(Boc)-OH |
97 |
zyl |
2024-12-18 |